Pages that link to "Item:Q2303919"
From MaRDI portal
The following pages link to Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor (Q2303919):
Displaying 14 items.
- Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy (Q2103601) (← links)
- Qualitative analysis and numerical simulations of new model describing cancer (Q2104076) (← links)
- Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model (Q2109247) (← links)
- Simulating the behaviour of glioblastoma multiforme based on patient MRI during treatments (Q2133942) (← links)
- A minimal modeling framework of radiation and immune system synergy to assist radiotherapy planning (Q2288507) (← links)
- Mathematical modeling of cancer radiovirotherapy (Q2488641) (← links)
- On modeling the synergy of cancer immunotherapy with radiotherapy (Q2684058) (← links)
- Stability and Hopf bifurcation of a tumor-immune system interaction model with an immune checkpoint inhibitor (Q2684070) (← links)
- THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING (Q5080062) (← links)
- Combination therapy for cancer with IL-27 and anti-PD-1: A simplified mathematical model (Q5879157) (← links)
- (Q6171090) (← links)
- IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer (Q6177320) (← links)
- Global dynamics of a tumor-immune model with an immune checkpoint inhibitor (Q6552497) (← links)
- Mathematical modeling and analysis of cancer treatment with radiation and anti-PD-L1 (Q6594588) (← links)